Wolfgang Miesbach: Practice-Changing Insights on the Efficacy and Safety of Platelet Transfusions at the EHA-SWG
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Platelet transfusions in inherited platelet disorders – powerful, but never ‘routine’
At the EHA‑SWG Scientific Meeting on Bleeding and Platelet Disorders, Roger Schutgens gave a practice‑changing talk on the efficacy and safety of platelet transfusions:
Platelet transfusions remain an important possibility.
But every unit carries a price:
- alloimmunization
- refractoriness
- TRALI/TACO– particularly critical for younger patients who may need repeated support.
What is striking:
Different societies suggest different platelet thresholds for the same procedures.
Many ‘strong’ recommendations are built on low or very low evidence.
In inherited platelet disorders, where function outweighs count, a single cutoff number is simply not enough.
‘Just give platelets’ is not a strategy.
We need individualized, phenotype‑driven decisions that balance immediate bleeding risk against the long‑term consequences of transfusion.”
Stay updated with Hemostasis Today.
-
Sep 28, 2026, 14:41Francois Roubille: Can Low-Dose Colchicine Prevent Atrial Fibrillation After CABG?
-
Sep 28, 2026, 14:39William Aird: Gulliver’s Atlas – Mapping the Evolution of the Vertebrate Red Cell
-
Sep 28, 2026, 14:30Rafael Zubiran: High Lp(a) Drives 1 in 15 Cases of Aortic Stenosis
-
Sep 28, 2026, 14:23Heghine Khachatryan: Measuring the Human Impact of Gene Therapy on the Hemophilia
-
Sep 28, 2026, 13:48Can the Immune System Be Reprogrammed to Treat Aplastic Anemia?
-
Sep 28, 2026, 13:20Elif Susan Elcin։ PRP for Skin Rejuvenation – Is It Worth the Hype?
-
Sep 28, 2026, 13:07Alexandru Stieber: Looking Beyond MDS in VEXAS Syndrome
-
Sep 28, 2026, 12:53Shifa Maharani: Research Innovation and Recognition at JSMID 8th
-
Sep 28, 2026, 12:40Najmul Hasan Forhad: Platelets – The Unsung Heroes of Hemostasis